Compounded semaglutide and tirzepatide subscription

Fresh Day Meds review

Fresh Day makes starter and transfer prices visible, but the renewal dates deserve equal attention: its GLP-1 policy says every 23 days for one-month plans and every 83 days for three-month plans. I would compare the total billed over time before treating the advertised monthly figure as a calendar-month cost.

Check your care options.

Confirm the medication, clinical access and recurring bill for your own plan.

Visit Fresh Day MedsOfficial provider website. No affiliate relationship is currently listed.

A fit for

Readers who will check starter versus transfer eligibility, exact recurring dates and the full conditional guarantee before choosing a compounded GLP-1 plan.

  • Current starter and transfer plan totals are separately listed.
  • Provider review, supplies and ongoing support are described.
  • Detailed guarantee and cancellation policies can be read before intake.

Tradeoffs to understand

Buyers expecting calendar-month billing, approved-brand trial results for a compound, or an unrestricted money-back trial.

  • Billing runs every 23 or 83 days under the current policy.
  • The guarantee requires four months and strict evidence and continuity.
  • Processed orders are not reversed by stopping future refills.
In this review

Use the exact total and renewal dates

Three-month tirzepatide is $420 for new-to-GLP-1 patients or $469 for transfers; the one-month plan is $179. Semaglutide is $299 or $385 for the respective three-month options, with a $140 one-month option. Monthly annotations are rounded: $99 multiplied by three is not the $299 semaglutide charge. Semaglutide describes three monthly shipments. [1] [2]

The current subscription policy specifies billing every 23 days for one-month GLP-1 plans and every 83 days for three-month plans. Obtain the dates and supply schedule before authorization. A continuous eligible plan has price-lock terms; changing or cancelling and restarting can change the price. No separate membership fee does not mean a calendar-month billing interval. [3]

The guarantee requires more than a three-month purchase

Care+ applies only when expressly included before purchase, for first-time Fresh Day weight patients who have never used GLP-1 or dual GLP-1/GIP treatment. Transfers, restarts and maintenance patients are excluded. It requires four calendar months from first confirmed medication delivery; an initial three-month purchase normally needs another paid renewal. Verified loss must be less than one pound. [4]

Automatic renewal must stay enabled through the completion cutoff. Confirmed cancellation, a future cancellation instruction, a pause or a treatment interruption can disqualify the claim—even with paid supply remaining. Medical advice takes priority: never continue unsafe treatment to retain this benefit. A pre-treatment starting video is due within 14 days of delivery; a fresh final video and timely claim are required by 14 days after completion, using the specified secure verification process. [4]

Approved claims refund covered initial and scheduled payments due and paid through completion, including covered medicine and consultation amounts, without the usual $75 retention. A qualifying renewal can be covered in full even if its supply extends beyond completion. No extra renewal is required solely during claim review after completion. A claim does not itself cancel billing. This is not an unconditional refund or clinical-results promise. [4]

Cancellation and nonapproval have different outcomes

A card hold reserves the plan price; payment is captured after physician approval. Initial medical nonapproval means no consultation charge and release of the hold. Cancelling or refusing after documented clinical work starts can incur $75, even without a prescription; nonresponse requires a final written notice of at least 24 hours. Queue entry alone is not clinical work. [5]

Stopping future renewals is free but requires confirmation; a ticket alone is insufficient. It does not cancel a current physician/pharmacy order or refund a processed renewal. Courtesy refunds are discretionary; $75 within each successful renewal may be retained, not added again. An approved Care+ claim overrides that retention. Prescription returns are not accepted. [3] [4] [5]

Check the actual prescription and delivery arrangement

Both reviewed GLP-1 products are compounded and not FDA-approved. Branded-drug trial percentages on the product pages do not establish the same outcome for these preparations. Clinical messaging is not a guaranteed immediate response or scheduled dietitian appointment. Ask for the exact ingredients, supply, dispenser and follow-up before enrollment. [1] [2] [4]

The shipping policy excludes Arkansas for compounded GLP-1 treatment. Product overnight marketing differs from its usual two-to-three-business-day injectable estimate after fulfillment. General terms pass carrier-handoff risk to patients, while the shipping policy provides confirmed-loss and qualifying-damage replacement procedures. Confirm the accepted agreement; damage reports are due within three days. [4] [6]

Understanding the cost

Tirzepatide: $179 one-month plan; three-month totals $420 new-to-GLP-1 or $469 transfer. Semaglutide: $140 one-month; three-month totals $299 new or $385 transfer. Current GLP-1 renewals run every 23/83 days, not calendar months; displayed monthly equivalents are rounded.

Build your cost estimate

Sources

  1. Fresh Day: tirzepatide plan options
  2. Fresh Day: semaglutide plan options
  3. Fresh Day: current GLP-1 billing and cancellation policy
  4. Fresh Day: full guarantee, service and purchase terms
  5. Fresh Day: consultation, payment and refund policy
  6. Fresh Day: shipping and replacement policy

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.